CLEARPOINT NEURO INC's ticker is CLPT and the CUSIP is 18507C103. A total of 29 filers reported holding CLEARPOINT NEURO INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $531,927 | -30.8% | 106,173 | 0.0% | 0.04% | -28.8% |
Q2 2023 | $768,693 | -5.9% | 106,173 | +9.7% | 0.06% | -10.6% |
Q1 2023 | $816,765 | -15.1% | 96,773 | -14.8% | 0.07% | -17.5% |
Q4 2022 | $962,099 | -15.3% | 113,589 | +3.6% | 0.08% | -21.6% |
Q3 2022 | $1,136,000 | -20.6% | 109,670 | +0.0% | 0.10% | -20.9% |
Q2 2022 | $1,431,000 | +25.4% | 109,648 | 0.0% | 0.13% | +50.0% |
Q1 2022 | $1,141,000 | -7.8% | 109,648 | -0.6% | 0.09% | -3.4% |
Q4 2021 | $1,238,000 | -34.3% | 110,322 | +4.0% | 0.09% | -39.5% |
Q3 2021 | $1,883,000 | -4.8% | 106,062 | +2.4% | 0.15% | -2.6% |
Q2 2021 | $1,978,000 | -7.0% | 103,612 | +3.0% | 0.15% | -13.2% |
Q1 2021 | $2,127,000 | -2.8% | 100,612 | -27.0% | 0.17% | -7.9% |
Q4 2020 | $2,189,000 | +156.0% | 137,784 | -12.0% | 0.19% | +127.7% |
Q3 2020 | $855,000 | +58.6% | 156,584 | +3.3% | 0.08% | +45.6% |
Q2 2020 | $539,000 | -0.7% | 151,584 | 0.0% | 0.06% | -18.6% |
Q1 2020 | $543,000 | – | 151,584 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Parian Global Management LP | 678,999 | $12,962,000 | 5.56% |
Taylor Frigon Capital Management LLC | 175,690 | $3,354,000 | 1.05% |
Mayo Clinic | 38,114 | $728,000 | 0.80% |
APIS CAPITAL ADVISORS, LLC | 40,000 | $764,000 | 0.66% |
Blackcrane Capital, LLC | 27,653 | $528,000 | 0.64% |
Parian Global Management LP | 75,000 | $1,432,000 | 0.62% |
Triumph Capital Management | 29,509 | $500,000 | 0.29% |
AlphaCentric Advisors LLC | 50,000 | $955,000 | 0.26% |
KIRR MARBACH & CO LLC /IN/ | 45,200 | $863,000 | 0.24% |
Kepos Capital LP | 125,000 | $2,386,000 | 0.18% |